Assessment of malaria transmission intensity using anti-MSP1-19 (Plasmodium vivax) antibody as a serological marker in a previously malaria endemic district in Sri Lanka | Zendy

Rajika Dewasurendra | Zendy; Nuno Sepúlveda | Zendy; S. Gunewardena | Zendy; N.V. Chandrasekharan | Zendy; Chris Drakeley | Zendy; Nadira D. Karunaweera | Zendy

Open Access

Assessment of malaria transmission intensity using anti-MSP1-19 (Plasmodium vivax) antibody as a serological marker in a previously malaria endemic district in Sri Lanka

Author(s) -

Rajika Dewasurendra,

Nuno Sepúlveda,

S. Gunewardena,

N.V. Chandrasekharan,

Chris Drakeley,

Nadira D. Karunaweera

Publication year - 2016

Publication title -

international journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.278

H-Index - 89

eISSN - 1878-3511

pISSN - 1201-9712

DOI - 10.1016/j.ijid.2016.02.779

Subject(s) - malaria , serology , plasmodium vivax , transmission (telecommunications) , population , antibody , veterinary medicine , biology , medicine , immunology , plasmodium falciparum , environmental health , electrical engineering , engineering

these two protein levels being much higher in the complicated vivax and falciparum infection than uncomplicated infection. Conclusion: Physicians should give equal importance to vivax as a cause of severe malaria as falciparum, with thrombocytopenia and jaundice being the most common complications. Policy makers should consider giving equal importance to severe vivax as severe falciparum and make amends in their action plan against malaria.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research